NHS England Hails Biggest CAR-T Uptake In Europe
But Cautions On Supply Chain Complexity
Executive Summary
Pharma must “speak the same language” as the National Health Service for “transactable” negotiations.
You may also be interested in...
Fair Pricing A Key Feature Of NHS England Drug Funding Proposals
Plans for a new commercial framework for publicly funded medicines in England are out for consultation. The concept of fair and responsible pricing figures large in the proposals.
UK NICE Changes Mind On Ocrevus After Roche Drops Price
Health technology assessment body NICE has changed its mind about the use of Ocrevus for treating primary progressive multiple sclerosis after Roche offered a lower price for the drug.
Precision Keeps Faith In Duchenne Gene-Editing After Lilly’s Exit
The company has pledged to continue developing its Duchenne in vivo gene editing therapy without Lilly, but will remain focused on its lead program in hepatitis B.